GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

Share · KR7082270000 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GemVax&KAEL Co.,Ltd
No Price
Closing Price XKOS 29.04.2026: 25.000,00 KRW
29.04.2026 06:30
Current Prices from GemVax&KAEL Co.,Ltd
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
082270.KQ
KRW
29.04.2026 06:30
25.000,00 KRW
0,00 KRW
Invested Funds

The following funds have invested in GemVax&KAEL Co.,Ltd:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
76,94
Percentage (%)
0,07 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
32,48
Percentage (%)
0,01 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
164,41
Percentage (%)
0,01 %
Company Profile for GemVax&KAEL Co.,Ltd Share
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. It operates through the Environmental Pollution Control project and Bio business divisions. The Environmental Pollution Control project business division focuses on the manufacture of filters necessary for the semiconductor and display manufacturing process and the air pollution/odor prevention equipment business. The Bio business division refers to the preparation for phase 2 and 3 clinical trials at home and abroad for various indications such as Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy with GV1001, a telomerase-derived peptide-based new drug substance. The company was founded on March 10, 1998 and is headquartered in Daejeon, South Korea.

Company Data

Name GemVax&KAEL Co.,Ltd
Company GemVax&KAEL Co.,Ltd
Website https://www.gemvax.com
Primary Exchange XKOS KOSDAQ
ISIN KR7082270000
Asset Class Share
Market Capitalization 1.052 Mrd.
Currency KRW
Employees -
IPO Date 2005-06-24
Dividends from 'GemVax&KAEL Co.,Ltd'
Ex-Date Dividend per Share
27.12.2007 150,00 KRW
27.12.2006 100,00 KRW
28.12.2005 50,00 KRW

Ticker Symbols

Name Symbol
KOSDAQ 082270.KQ
More Shares
Investors who hold GemVax&KAEL Co.,Ltd also have the following shares in their portfolio:
LIF-600 TR.+LEI EOA
LIF-600 TR.+LEI EOA ETF
TRITBOX REIT 20/33
TRITBOX REIT 20/33 Bond